Bayer

ALIQOPA

Manufacturer:

Bayer

Aliqopa HCPCS:

J9057

HCPCS Code Descriptor:

Injection, copanlisib, 1 mg

Category:

J Code

Aliqopa NDCs:

50419-0385-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Aliqopa:

ALIQOPA is an Oncology drug manufactured by Bayer and administered via the Intravenous route of administration. The J Code: J9057 is aligned to the drug ALIQOPA.

ACCESS PRICING AND MORE BY REGISTERING

J9057 Added Date:

January 1, 2019

J9057 Effective Date:

January 1, 2019

J9057 Termination Date:

HCPCS Active

Aliqopa billing and coding information can be found through Bayer at the link below:
Aliqopa patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.patientassistance.bayer.us/
ALIQOPA prescribing information can be found at the link below:
Information regarding ALIQOPA’s side effects can be found at MedlinePlus